Drug
Mcla 158
Mcla 158: highest development phase Phase 1/2, developed by Merus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Merus
Trials
| Drug | Phase | Indication |
|---|---|---|
| MCLA-158 NCT03526835 | Phase 1/2 | Advanced/Metastatic Solid Tumors |
Latest
No recent events.
Follow Mcla 158 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.